The Role of BTKi's in the Management of CLL
This webinar was recorded on Jan. 10, 2023
Sponsored by BeiGene
This webinar featured a candid conversation with panelists from AMCP’s Market Insights Roundtable on The Role of BTKi’s in the Management of CLL. Speakers will provide an overview of the current and evolving coverage and treatment landscapes for managing CLL.
Speakers shared insights from the roundtable discussion which included current approaches to the treatment of CLL< the clinical information regarding the BTKi class and current and future approaches to the development of protocols and treatment pathways. As more treatment options are available for CLL, payers discussed approaches to management and partnering with their provider network.
The program was facilitated by participants of the program.
- Ryan Haumschild, Pharm D, MS, MBA
Director of Pharmacy Services
Emory Healthcare and Winship Cancer Institute
- Bhavesh Shah
Chief Pharmacy Officer Specialty and Hematology Oncology Pharmacy
Boston Medical Center (BMC)